Association between human demodicosis and HLA class I

Clinical and Experimental Dermatology

Volumn 28, Issue 1, 2003, Pages 70-73

  Akilov, O E ^a   Mumcuoglu, K Y ^b,c  

^a Department of Dermatology   (Russian Federation)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1;

ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE ACTIVATION; DEMODEX; DEMODICIDOSIS; HAIR FOLLICLE; HAPLOTYPE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MACROPHAGE ACTIVATION; NATURAL KILLER CELL; PRIORITY JOURNAL; SKIN DISEASE; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; ALLELES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; SKIN DISEASES, PARASITIC;

EID: 0037272764     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2003.01173.x     Document Type: Article

References (28)

1. Zareckaya YM. Clinical Immunogenetics. Moscow: Medicine Publications, 1983:133-43.
2. Akilov OE, Smirnova NS. Epidemiology of Human Demodicosis. In: An Actual Problem in Plastic Surgery, Aesthetic Surgery and Cosmetology. Moscow: Triada Pharm Publications. 2001:65-74.
3. Liao NS, Bix M, Zijlstra Met al. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 1991; 253: 199-202.
4. Akilov OE, Kazanceva SV, Vlasova IA. The immune system in human demodicosis (in Russian). Med Immunol 2001; 3: 211.
5. Yazdovsky VV, Voronin AV, Alexeev LP. HLA genetic profile of Russian population (In Russian). Immunology 1998; 2: 30-1.
6. Baksht BP. The role of Demodex folliculorum hominis mite in human skin pathology (in Russian). Vestn Dermatol Venerol 1965; 7: 31-6.
7. Terasaki PI, McClelland JD. Microdroplet assay of human serum cytotoxins. Nature 1964; 204: 998-1000.
8. Mattiuz RL, Ihde D, Piazza A. et al. New approaches to the population genetic and segregation analysis of the HLA system. In: Terasaki, PI, ed. Histocompatibility Testing. Copenhagen: Munksgaard, 1970:193-205.
9. Hawkins BR. Table of critical chi-square values for investigations involving multiple comparisons. Tissue Antigens 1981; 17: 234-44.
10. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955; 19: 251-3.
11. Green A. The epidemiologic approach to studies of association between HLA and disease. II. Estimation of absolute risks, etiologic and preventive fraction. Tissue Antigens 1982; 19: 259-68.
12. Rufli T, Buchner SA. T-cell subsets in acne rosacea lesions and the possible role of Demodex folliculorum. Dermatologica 1984; 169: 1-11.
13. Bakker AB. Phillips JH, Figdor CG. Lanier LL. Killer cell inhibitory receptors for MHC class molecules regulate lysis of melanoma cells mediated NK cells, gamma delta T cells, and antigen-specific CTL. J Immunol 1998; 160: 5239-45.
14. Karre K. Express yourself or die. Peptides, MHC molecules, and NK cells [comment]. Science 1995; 267: 978-9.
15. Lanier LL. Activating and inhibitory NK cell receptors. Adv Exp Med Biol 1998; 452: 13-8.
16. Lanier LL. NK cell receptors. Annu Rev Immunol 1998; 16: 359-93.
17. Chadwick BS, Miller RG. Hybrid resistance in vitro. Possible role of both class I MHC and self peptides in determining the level of target cell sensitivity. J Immunol 1992; 148: 2307-13.
18. Moretta A. Vitale M, Sivori S et al. Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-alleles. J Exp Med 1994; 180: 545-55.
19. Wu MF, Raulet DH. Class I-deficient hemopoietic cells nonhemopoietic cells dominantly induce unresponsiveness of natural killer cells to class I-deficient bone marrow cell grafts. J Immunol 1997; 158: 1628-33.
20. Takei F, Brennan J, Mager DL. The Ly-49 family: genes, proteins and recognition of class I MHC. Immunol Rev 1997; 155: 67-77.
21. Yokoyama WM, Seaman WE. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu Rev Immunol 1993; 11: 613-35.
22. Braud VM, Allan DS, O'Callaghan CA et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998; 391: 795-9.
23. Lanier LL, Phillips JH, Inhibitory MHC class I receptors on NK cells T. cells. Immunol Today 1996; 17: 86-91.
24. Leibson PJ. MHC-recognizing receptors: they're not just for T cells anymore. Immunity 1995; 3: 5-8.
25. Pende D, Sivori S, Accame L et al. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex. Eur J Immunol 1997; 27: 1875-80.
26. Phillips JH, Chang C, Mattson J et al. CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. Immunity 1996; 5: 163-72.
27. Soderstrom K, Corliss B, Lanier LL, Phillips JH. CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells. J Immunol 1997; 159: 1072-5.
28. Falk CS, Steinle A, Schendel DJ. Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells. J Exp Med 1995; 182: 1005-18.